Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 14

The EGFR Polymorphism Increased the Risk of Hepatocellular Carcinoma Through the miR-3196-Dependent Approach in Chinese Han Population [Corrigendum]

Authors Zhang L, Li X, Lu J, Qian Y, Qian T, Wu X, Xu Q

Received 12 November 2021

Accepted for publication 12 November 2021

Published 30 December 2021 Volume 2021:14 Pages 1715—1716

DOI https://doi.org/10.2147/PGPM.S349137



Zhang L, Li X, Lu J, et al. Pharmgenomics Pers Med. 2021;14:469–476.

Page 470, Materials and Methods, Clinical Samples, second sentence, the text “All blood samples are taken from Liyang People’s Hospital during March 2009 to August 2019” should read “All blood samples are taken from Liyang Branch of Jiangsu Province Hospital and Jiangsu Province Hospital during March 2009 to August 2019”.

The authors apologize for this error.

Read the original article

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.